Oxcarbazepine versus Divalproex Sodium for the Continuing Treatment of Mania

Author： Reinstein M.J.   Sonnenberg J.G.   Hedberg T.G.   Jones L.E.   Reyngold P.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.10, 2003-01, pp. : 671-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Divalproex Sodium for the Treatment of Behavioural Problems Associated With Dementia in the Elderly

By Porsteinsson Anton P.  

Drugs & Aging, Vol. 23, Iss. 11, 2006-01 ,pp. : 877-886

Adis International

Access to resources Recommend Favorite

Divalproex sodium extended-release for the prophylaxis of migraine headache

By Freitag Fred G  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1573-1578

Informa Healthcare

Access to resources Recommend Favorite

Bioavailability of a Divalproex Extended-Release Formulation versus the Conventional Divalproex Formulation in Adult Patients Receiving Enzyme-Inducing Antiepileptic Drugs

By Sommerville K.W.  

Clinical Drug Investigation, Vol. 23, Iss. 10, 2003-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

Effect of Divalproex Sodium on Behavioural and Cognitive Problems in Elderly Dementia

By Meinhold Jane M.  

Drugs & Aging, Vol. 22, Iss. 7, 2005-01 ,pp. : 615-626

Adis International

Access to resources Recommend Favorite

Development of Extended Release Divalproex Sodium Tablets Containing Hypdrophobic and Hydrophilic Matrix

By  

Current Drug Delivery, Vol. 6, Iss. 3, 2009-07 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite